SPECT IMAGING OF DOPAMINE D2 RECEPTORS WITH 2'-IODOSPIPERONE

被引:0
作者
IWASAKI, Y
YONEKURA, Y
SAJI, H
NISHIZAWA, S
FUKUYAMA, H
IIDA, Y
MAGATA, Y
SHIBASAKI, H
YOKOYAMA, A
KONISHI, J
机构
[1] KYOTO UNIV,DEPT NUCL MED,KYOTO,JAPAN
[2] KYOTO UNIV,DEPT BRAIN PATHOPHYSIOL,KYOTO,JAPAN
[3] KYOTO UNIV,DEPT RADIOPHARMACEUT SCI,KYOTO,JAPAN
[4] KYOTO UNIV,DEPT NEUROL,KYOTO,JAPAN
关键词
SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY; DOPAMINE D2 RECEPTOR; IODINE-123-2'-IODOSPIPERONE;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
SPECT imaging of dopamine D2 receptors was performed using I-123-labeled 2'-iodospiperone (2'-ISP). Methods: Iodine-123-2'-ISP was administered to 12 normal subjects. Serial SPECT scans were obtained in six normal subjects for kinetic studies and static SPECT images were obtained in four normal subjects. Two additional normal subjects had serial whole-body imaging to calculate radiation dosimetry. Results: Serial SPECT scans demonstrated rapid initial brain uptake followed by gradual washout from the cerebral cortex and cerebellum, while the activity in the basal ganglia was stable for 2 hr and gradually decreased thereafter. There was fast clearance of blood activity with rapid conversion of 2'-ISP to the hydrophilic metabolites. The basal ganglia-to-frontal cortex ratio increased with time and plateaued between 2 and 4 hr postinjection. The basal ganglia-to-frontal cortex ratio obtained during this period demonstrated an age-dependent decrease similar to other D2 ligands. Conclusion: 2'-ISP can be used for mapping dopamine D2 receptors in human brain with SPECT. The relatively high background activity, however, suggests that further modification of the compound may be needed prior to widespread clinical use.
引用
收藏
页码:1191 / 1195
页数:5
相关论文
共 22 条
[1]  
ARNETT CD, 1986, J NUCL MED, V27, P1878
[2]   LOSS OF STRIATAL [BR-76] BROMOSPIPERONE BINDING-SITES DEMONSTRATED BY POSITRON TOMOGRAPHY IN PROGRESSIVE SUPRANUCLEAR PALSY [J].
BARON, JC ;
MAZIERE, B ;
LOCH, C ;
CAMBON, H ;
SGOUROPOULOS, P ;
BONNET, AM ;
AGID, Y .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1986, 6 (02) :131-136
[3]  
BRUCKE T, 1991, J CEREBR BLOOD F MET, V11, P220
[4]  
CHABRIAT H, 1992, J NUCL MED, V33, P1481
[5]  
COENEN HH, 1988, EUR J NUCL MED, V14, P80
[6]  
DANNALS RF, 1990, QUANTITATIVE IMAGING, P19
[7]   PREPARATION OF C-11-LABELLED RACLOPRIDE, A NEW POTENT DOPAMINE RECEPTOR ANTAGONIST - PRELIMINARY PET STUDIES OF CEREBRAL DOPAMINE-RECEPTORS IN THE MONKEY [J].
EHRIN, E ;
FARDE, L ;
DEPAULIS, T ;
ERIKSSON, L ;
GREITZ, T ;
JOHNSTROM, P ;
LITTON, JE ;
NILSSON, JLG ;
SEDVALL, G ;
STONEELANDER, S ;
OGREN, SO .
INTERNATIONAL JOURNAL OF APPLIED RADIATION AND ISOTOPES, 1985, 36 (04) :269-&
[8]   KINETIC-ANALYSIS OF CENTRAL [C-11] RACLOPRIDE BINDING TO D2-DOPAMINE RECEPTORS STUDIED BY PET - A COMPARISON TO THE EQUILIBRIUM-ANALYSIS [J].
FARDE, L ;
ERIKSSON, L ;
BLOMQUIST, G ;
HALLDIN, C .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1989, 9 (05) :696-708
[9]  
HATANO K, 1989, J NUCL MED, V30, P515
[10]  
KUNG HF, 1989, J NUCL MED, V30, P88